{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:27:59Z","timestamp":1772497679609,"version":"3.50.1"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>PU.1-mutated agammaglobulinemia (PU.MA) represents a recently described autosomal-dominant form of agammaglobulinemia caused by mutation of the <jats:italic>SPI1<\/jats:italic> gene. This gene codes for PU.1 pioneer transcription factor important for the maturation of monocytes, B lymphocytes, and conventional dendritic cells. Only six cases with PU.MA, presenting with chronic sinopulmonary and systemic enteroviral infections, have been previously described. Accumulating literature evidence suggests a possible relationship between <jats:italic>SPI1<\/jats:italic> mutation, microglial phagocytic dysfunction, and the development of Alzheimer\u2019s disease (AD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>We present a Caucasian female patient born from a non-consanguineous marriage, who was diagnosed with agammaglobulinemia at the age of 15 years when the immunoglobulin replacement therapy was started. During the following seventeen years, she was treated for recurrent respiratory and intestinal infections. At the age of 33 years, the diagnosis of celiac-like disease was established. Five years later progressive cognitive deterioration, unstable gait, speech disturbances, and behavioral changes developed. Comprehensive microbiological investigations were negative, excluding possible infective etiology. Brain MRI, <jats:sup>18<\/jats:sup>FDG-PET-CT, and neuropsychological testing were suggestive for a diagnosis of a frontal variant of AD. Clinical exome sequencing revealed the presence of a novel frameshift heterozygous variant c.441dup in exon 4 of the <jats:italic>SPI1<\/jats:italic> gene. Despite intensive therapy, the patient passed away a few months after the onset of the first neurological symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>We describe the first case of PU.MA patient presenting with a rapidly progressive neurocognitive deterioration. The possible role of microglial dysfunction in patients with <jats:italic>SPI1<\/jats:italic> mutation could explain their susceptibility to neurodegenerative diseases thus highlighting the importance of genetic testing in patients with inborn errors of immunity. Since PU.MA represents a newly described form of agammaglobulinemia, our case expands the spectrum of manifestations associated with <jats:italic>SPI1<\/jats:italic> mutation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1324679","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:22:48Z","timestamp":1709547768000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: Rapidly progressive neurocognitive disorder with a fatal outcome in a patient with PU.1 mutated agammaglobulinemia"],"prefix":"10.3389","volume":"15","author":[{"given":"Rada","family":"Miskovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Ljubicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branka","family":"Bonaci-Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Petkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladana","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Rankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Djordjevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristel","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Stojanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.immunol.021908.132649","article-title":"Primary B cell immunodeficiencies: comparisons and contrasts","volume":"27","author":"Conley","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s12016-021-08870-5","article-title":"Agammaglobulinemia: from X-linked to autosomal forms of disease","volume":"63","author":"Cardenas-Morales","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201750","article-title":"Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients","volume":"218","author":"Le Coz","year":"2021","journal-title":"J Exp Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-015-1762-8","article-title":"The RUNX1\u2013PU.1 axis in the control of hematopoiesis","volume":"101","author":"Imperato","year":"2015","journal-title":"Int J Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.immuni.2018.11.010","article-title":"Transcription factor PU.1 promotes conventional dendritic cell identity and function via induction of transcriptional regulator DC-SCRIPT","volume":"50","author":"Chopin","year":"2019","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221105","article-title":"Inborn errors of human B cell development, differentiation, and function","volume":"220","author":"Tangye","year":"2023","journal-title":"J Exp Med"},{"key":"B8","volume-title":"BioFire Diagnostics -The BioFire\u00ae FilmArray\u00ae Gastrointestinal (GI) Panel","year":"2023"},{"key":"B9","volume-title":"BioFire Diagnostics -The BioFire\u00ae FilmArray\u00ae Meningitis\/Encephalitis (ME) Panel","year":"2023"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt355","article-title":"Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1","volume":"41","author":"Pham","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9892-3","article-title":"The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency","volume":"33","author":"Venhoff","year":"2013","journal-title":"J Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21040","article-title":"Gastrointestinal manifestations in primary immune disorders","volume":"16","author":"Agarwal","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12761","article-title":"Norovirus infection in immunocompromised hosts","volume":"20","author":"Green","year":"2014","journal-title":"Clin Microbiol Infection"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw497","article-title":"Nitazoxanide is an ineffective treatment of chronic norovirus in patients with X-linked agammaglobulinemia and may yield false-negative polymerase chain reaction findings in stool specimens","volume":"215","author":"Kempf","year":"2017","journal-title":"J Infect Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2023.e01737","article-title":"Unsuccessful treatment of chronic norovirus infection with enteral immunoglobulin in patients with common variable immunodeficiency, case report","volume":"32","author":"Christensen","year":"2023","journal-title":"IDCases"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1926","article-title":"Norovirus infection in primary immune deficiency","volume":"27","author":"Brown","year":"2017","journal-title":"Rev Med Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/med.21545","article-title":"Norovirus antivirals: Where are we now","volume":"39","author":"Netzler","year":"2019","journal-title":"Medicinal Res Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1207742","article-title":"Norovirus gastroenteritis in immunocompromised patients","volume":"367","author":"Bok","year":"2012","journal-title":"New Engl J Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23126729","article-title":"Combined approach to leukemic differentiation using transcription factor PU.1-enhancing agents","volume":"23","author":"Ba\u0161ov\u00e1","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2049","article-title":"Viral infection in primary antibody deficiency syndromes","volume":"29","author":"Jones","year":"2019","journal-title":"Rev Med Virol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.016","article-title":"Recurrent and persistent respiratory tract viral infections in patients with primary hypogammaglobulinemia","volume":"126","author":"Kainulainen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jaip.2020.08.016","article-title":"Increased respiratory viral detection and symptom burden among patients with primary antibody deficiency: results from the BIPAD study","volume":"9","author":"Ponsford","year":"2021","journal-title":"J Allergy Clin Immunology: In Practice"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.10.031","article-title":"Treatment of chronic or relapsing COVID-19 in immunodeficiency","volume":"149","author":"Brown","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"Avanzato","year":"2020","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"New Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.106685","article-title":"COVID-19 relapse associated with SARS-CoV-2 evasion from CD4+ T-cell recognition in an agammaglobulinemia patient","volume":"26","author":"Morita","year":"2023","journal-title":"iScience"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01480-0","article-title":"Monoclonal antibodies for COVID-19 in X-linked agammaglobulinemia: a case series","volume":"43","author":"Simard","year":"2023","journal-title":"J Clin Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19761-2","article-title":"Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report","volume":"11","author":"Buckland","year":"2020","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-023-01152-0","article-title":"Norovirus-associated neurological manifestations: summarizing the evidence","volume":"29","author":"Deb","year":"2023","journal-title":"J Neurovirol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.03.2010.2784","article-title":"An adult norovirus-related encephalitis\/encephalopathy with mild clinical manifestation","author":"Kimura","year":"2010","journal-title":"BMJ Case Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s40734-017-0052-4","article-title":"Diagnosing the frontal variant of Alzheimer\u2019s disease: a clinician\u2019s yellow brick road","volume":"4","author":"Sawyer","year":"2017","journal-title":"J Clin Mov Disord"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm213","article-title":"Focal cortical presentations of Alzheimer\u2019s disease","volume":"130","author":"Alladi","year":"2007","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt155","article-title":"Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome","volume":"5","author":"Lam","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2020192541","article-title":"Cross-sectional and longitudinal assessment of brain iron level in Alzheimer disease using 3-T MRI","volume":"296","author":"Damulina","year":"2020","journal-title":"Radiology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5339","article-title":"Assessment of iron deposition in the brain in frontotemporal dementia and its correlation with behavioral traits","volume":"38","author":"Sheelakumari","year":"2017","journal-title":"Am J Neuroradiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv191","article-title":"The behavioural\/dysexecutive variant of Alzheimer\u2019s disease: Clinical, neuroimaging and pathological features","volume":"138","author":"Ossenkoppele","year":"2015","journal-title":"Brain"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/1744666X.2021.2008241","article-title":"Gut inflammation in CVID: causes and consequences","volume":"18","author":"Andersen","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl081","article-title":"Primary Whipple\u2019s disease of the brain: Characterization of the clinical syndrome and molecular diagnosis","volume":"99","author":"Panegyres","year":"2006","journal-title":"QJM"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1548","article-title":"Frontal variant of Alzheimer\u2019s disease with asymmetric presentation mimicking frontotemporal dementia: Case report and literature review","volume":"10","author":"Li","year":"2020","journal-title":"Brain Behav"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1590\/S1980-57642013DN70100011","article-title":"Frontal presentation of Alzheimer\u2019s disease A series of patients with biological evidence by CSF biomarkers","volume":"7","author":"Cruz de Souza","year":"2013","journal-title":"Dement Neuropsychol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.brain.2023.100063","article-title":"Iron level changes in the brain with neurodegenerative disease","volume":"4","author":"Bazala","year":"2023","journal-title":"Brain Multiphys"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/01.wco.0000137534.61244.d1","article-title":"Neurodegenerative disease and iron storage in the brain","volume":"17","author":"Thomas","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-161143","article-title":"Cortical iron reflects severity of Alzheimer\u2019s disease","volume":"60","author":"Van Duijn","year":"2017","journal-title":"J Alzheimer\u2019s Disease"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00194","article-title":"Increased iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in Alzheimer\u2019s disease","volume":"9","author":"Du","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiol.2532082324","article-title":"Quantitative MR phase-corrected imaging to investigate increased brain iron deposition of patients with Alzheimer disease","volume":"253","author":"Zhu","year":"2009","journal-title":"Radiology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.830569","article-title":"Iron dyshomeostasis and ferroptosis: A new Alzheimer\u2019s disease hypothesis","volume":"14","author":"Wang","year":"2022","journal-title":"Front Aging Neurosci Front Media S.A"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/brv.12521","article-title":"Brain iron transport","volume":"94","author":"Qian","year":"2019","journal-title":"Biol Rev"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/glia.22486","article-title":"The transcription factor PU.1 is critical for viability and function of human brain microglia","volume":"61","author":"Smith","year":"2013","journal-title":"Glia"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa089","article-title":"Relationship between cortical iron and tau aggregation in Alzheimer\u2019s disease","volume":"143","author":"Spotorno","year":"2020","journal-title":"Brain"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","article-title":"Iron (III) induces aggregation of hyperphosphorylated s and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer\u2019s disease","volume":"82","author":"Yamamoto","year":"2002","journal-title":"J\u00a0Neurochem"},{"key":"B53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/rej.2006.9096","article-title":"Evidence that aging and amyloid promote microglial cell senescence","volume":"10","author":"Flanary","year":"2007","journal-title":"Rejuvenation Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1125982","article-title":"Microglia: A pharmacological target for the treatment of age-related cognitive decline and Alzheimer\u2019s disease","volume":"14","author":"McKee","year":"2023","journal-title":"Front Pharmacol Front Media S.A"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37304-3","article-title":"An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer\u2019s disease","volume":"14","author":"Lau","year":"2023","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2022.838692","article-title":"Iron and Alzheimer\u2019s disease: from pathology to imaging","volume":"16","author":"Tran","year":"2022","journal-title":"Front Hum Neurosci Front Media S.A"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat Genet"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215311","article-title":"Association of SPI1 haplotypes with altered SPI1 gene expression and Alzheimer\u2019s disease risk","volume":"86","author":"Cao","year":"2022","journal-title":"J\u00a0Alzheimer\u2019s Disease"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04516-6","article-title":"Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer\u2019s disease, Parkinson\u2019s disease, and multiple sclerosis","volume":"21","author":"Fan","year":"2023","journal-title":"J Transl Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105217","article-title":"Alzheimer\u2019s-associated PU.1 expression levels regulate microglial inflammatory response","volume":"148","author":"Pimenova","year":"2021","journal-title":"Neurobiol Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/v14040725","article-title":"Amyloid and tau protein concentrations in children with meningitis and encephalitis","volume":"14","author":"Sulik","year":"2022","journal-title":"Viruses"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324679\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T10:23:00Z","timestamp":1709547780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1324679\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":62,"alternative-id":["10.3389\/fimmu.2024.1324679"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1324679","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,4]]},"article-number":"1324679"}}